Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
This report offers an overview of the market trends, drivers, and barriers with respect to the USA T-Cell Immunotherapy market. It also provides a detailed overview of the market of different regions across West USA, South USA, Middle West USA, Northeast USA. The report deeply analyzes type and application in the USA T-Cell Immunotherapy market. Detailed analysis of key players, along with key growth strategies adopted by T-Cell Immunotherapy industry, the PEST and SWOT analysis are also included. In short, the report will provide a comprehensive view of the industry's development and features.
By Player:
Kite Pharma
Adaptimmune
Juno Therapeutics
Novartis
Unum Therapeutics
Altor Bioscience Corporation
Takara Bio
Cellectis
By Type:
CAR-T
TCR
TIL Therapies
By End-User:
Stomach Cancer
Lung Cancer
Colorectal Cancer
Esophagus Cancer
Pancreatic Cancer
Others
By Region:
-
West USA
-
South USA
-
Middle West USA
-
Northeast USA
TABLE OF CONTENT
1 Report Overview
-
1.1 Product Definition and Scope
-
1.2 PEST (Political, Economic, Social and Technological) Analysis of T-Cell Immunotherapy Market
-
1.3 Market Segment by Type
-
1.3.1 USA T-Cell Immunotherapy Market Size and Growth Rate of CAR-T from 2016 to 2027
-
1.3.2 USA T-Cell Immunotherapy Market Size and Growth Rate of TCR from 2016 to 2027
-
1.3.3 USA T-Cell Immunotherapy Market Size and Growth Rate of TIL Therapies from 2016 to 2027
-
1.4 Market Segment by Application
-
1.4.1 USA T-Cell Immunotherapy Market Size and Growth Rate of Stomach Cancer from 2016 to 2027
-
1.4.2 USA T-Cell Immunotherapy Market Size and Growth Rate of Lung Cancer from 2016 to 2027
-
1.4.3 USA T-Cell Immunotherapy Market Size and Growth Rate of Colorectal Cancer from 2016 to 2027
-
1.4.4 USA T-Cell Immunotherapy Market Size and Growth Rate of Esophagus Cancer from 2016 to 2027
-
1.4.5 USA T-Cell Immunotherapy Market Size and Growth Rate of Pancreatic Cancer from 2016 to 2027
-
1.4.6 USA T-Cell Immunotherapy Market Size and Growth Rate of Others from 2016 to 2027
-
1.5 Market Segment by Regions
-
1.5.1 West USA T-Cell Immunotherapy Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.2 South USA T-Cell Immunotherapy Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.3 Middle West USA T-Cell Immunotherapy Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.4 Northeast USA T-Cell Immunotherapy Consumption Market Size and Growth Rate from 2016 to 2027
2 Market Trends and Competitive Landscape
-
2.1 Market Trends and Dynamics
-
2.1.1 Market Challenges and Restraints
-
2.1.2 Market Opportunities and Potentials
-
2.1.3 Mergers and Acquisitions
-
2.2 Competitive Landscape Analysis
-
2.2.1 Industrial Concentration Analysis
-
2.2.2 Porter's Five Forces Analysis of the Industry
-
2.2.3 SWOT Analysis for New Entrants
-
2.3 Coronavirus (COVID-19) Distribution and its Impact on the Industry
3 Segmentation of T-Cell Immunotherapy Market by Types
-
3.1 Products Development Trends of Different Types
-
3.2 Products Types of Major Vendors
-
3.3 Competitive Landscape Analysis of Different Types
-
3.4 Market Size of T-Cell Immunotherapy by Major Types
-
3.4.1 Market Size and Growth Rate of CAR-T
-
3.4.2 Market Size and Growth Rate of TCR
-
3.4.3 Market Size and Growth Rate of TIL Therapies
4 Segmentation of T-Cell Immunotherapy Market by End-Users
-
4.1 Downstream Client Analysis by End-Users
-
4.2 Competitive Landscape Analysis of Different End-Users
-
4.3 Market Potential Analysis of Different End-Users
-
4.4 Market Size of T-Cell Immunotherapy by Major End-Users
-
4.4.1 Market Size and Growth Rate of T-Cell Immunotherapy in Stomach Cancer
-
4.4.2 Market Size and Growth Rate of T-Cell Immunotherapy in Lung Cancer
-
4.4.3 Market Size and Growth Rate of T-Cell Immunotherapy in Colorectal Cancer
-
4.4.4 Market Size and Growth Rate of T-Cell Immunotherapy in Esophagus Cancer
-
4.4.5 Market Size and Growth Rate of T-Cell Immunotherapy in Pancreatic Cancer
-
4.4.6 Market Size and Growth Rate of T-Cell Immunotherapy in Others
5 Market Analysis by Regions
-
5.1 USA T-Cell Immunotherapy Production Analysis by Regions
-
5.2 USA T-Cell Immunotherapy Consumption Analysis by Regions
-
5.3 Coronavirus (COVID-19) Impact on USA Economy
6 West USA T-Cell Immunotherapy Landscape Analysis
-
6.1 West USA T-Cell Immunotherapy Landscape Analysis by Major Types
-
6.2 West USA T-Cell Immunotherapy Landscape Analysis by Major End-Users
7 South USA T-Cell Immunotherapy Landscape Analysis
-
7.1 South USA T-Cell Immunotherapy Landscape Analysis by Major Types
-
7.2 South USA T-Cell Immunotherapy Landscape Analysis by Major End-Users
8 Middle West USA T-Cell Immunotherapy Landscape Analysis
-
8.1 Middle West USA T-Cell Immunotherapy Landscape Analysis by Major Types
-
8.2 Middle West USA T-Cell Immunotherapy Landscape Analysis by Major End-Users
9 Northeast USA T-Cell Immunotherapy Landscape Analysis
-
9.1 Northeast USA T-Cell Immunotherapy Landscape Analysis by Major Types
-
9.2 Northeast USA T-Cell Immunotherapy Landscape Analysis by Major End-Users
10 Major Players Profiles
-
10.1 Kite Pharma
-
10.1.1 Kite Pharma Company Profile and Recent Development
-
10.1.2 Market Performance
-
10.1.3 Product and Service Introduction
-
10.2 Adaptimmune
-
10.2.1 Adaptimmune Company Profile and Recent Development
-
10.2.2 Market Performance
-
10.2.3 Product and Service Introduction
-
10.3 Juno Therapeutics
-
10.3.1 Juno Therapeutics Company Profile and Recent Development
-
10.3.2 Market Performance
-
10.3.3 Product and Service Introduction
-
10.4 Novartis
-
10.4.1 Novartis Company Profile and Recent Development
-
10.4.2 Market Performance
-
10.4.3 Product and Service Introduction
-
10.5 Unum Therapeutics
-
10.5.1 Unum Therapeutics Company Profile and Recent Development
-
10.5.2 Market Performance
-
10.5.3 Product and Service Introduction
-
10.6 Altor Bioscience Corporation
-
10.6.1 Altor Bioscience Corporation Company Profile and Recent Development
-
10.6.2 Market Performance
-
10.6.3 Product and Service Introduction
-
10.7 Takara Bio
-
10.7.1 Takara Bio Company Profile and Recent Development
-
10.7.2 Market Performance
-
10.7.3 Product and Service Introduction
-
10.8 Cellectis
-
10.8.1 Cellectis Company Profile and Recent Development
-
10.8.2 Market Performance
-
10.8.3 Product and Service Introduction
The List of Tables and Figures
-
Figure Product Picture
-
Figure USA T-Cell Immunotherapy Market Size and Growth Rate of CAR-T from 2016 to 2027
-
Figure USA T-Cell Immunotherapy Market Size and Growth Rate of TCR from 2016 to 2027
-
Figure USA T-Cell Immunotherapy Market Size and Growth Rate of TIL Therapies from 2016 to 2027
-
Figure Market Share by Type in 2016
-
Figure Market Share by Type in 2020
-
Figure Market Share by Type in 2027
-
Figure USA T-Cell Immunotherapy Market Size and Growth Rate of Stomach Cancer from 2016 to 2027
-
Figure USA T-Cell Immunotherapy Market Size and Growth Rate of Lung Cancer from 2016 to 2027
-
Figure USA T-Cell Immunotherapy Market Size and Growth Rate of Colorectal Cancer from 2016 to 2027
-
Figure USA T-Cell Immunotherapy Market Size and Growth Rate of Esophagus Cancer from 2016 to 2027
-
Figure USA T-Cell Immunotherapy Market Size and Growth Rate of Pancreatic Cancer from 2016 to 2027
-
Figure USA T-Cell Immunotherapy Market Size and Growth Rate of Others from 2016 to 2027
-
Figure Market Share by End-User in 2016
-
Figure Market Share by End-User in 2020
-
Figure Market Share by End-User in 2027
-
Figure West USA T-Cell Immunotherapy Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure South USA T-Cell Immunotherapy Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Middle West USA T-Cell Immunotherapy Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Northeast USA T-Cell Immunotherapy Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Development Trends and Industry Dynamics of T-Cell Immunotherapy Industry
-
Figure Market Challenges and Restraints
-
Figure Market Opportunities and Potentials
-
Table Mergers and Acquisition
-
Figure Market Share of TOP 3 Players in 2019
-
Figure Market Share of TOP 5 Players in 2019
-
Figure Market Share of TOP 6 Players from 2016 to 2020
-
Figure Porter's Five Forces Analysis
-
Figure New Entrant SWOT Analysis
-
Figure Coronavirus (COVID-19) Distribution Map of USA
-
Table Coronavirus (COVID-19) Impact on the Industry
-
Figure Specifications of Different Types of T-Cell Immunotherapy
-
Figure Development Trends of Different Types
-
Table Products Types of Major Vendors
-
Figure Competitive Landscape Analysis of Different Types
-
Table Consumption of T-Cell Immunotherapy by Different Types from 2016 to 2027
-
Table Consumption Share of T-Cell Immunotherapy by Different Types from 2016 to 2027
-
Figure Market Size and Growth Rate of CAR-T
-
Figure Market Size and Growth Rate of TCR
-
Figure Market Size and Growth Rate of TIL Therapies
-
Table Downstream Client Analysis by End-Users
-
Figure Competitive Landscape Analysis of Different End-Users
-
Table Market Potential Analysis of Different End-Users
-
Figure Consumption of T-Cell Immunotherapy by Different End-Users from 2016 to 2027
-
Table Consumption Share of T-Cell Immunotherapy by Different End-Users from 2016 to 2027
-
Figure Market Size and Growth Rate of Stomach Cancer
-
Figure Market Size and Growth Rate of Lung Cancer
-
Figure Market Size and Growth Rate of Colorectal Cancer
-
Figure Market Size and Growth Rate of Esophagus Cancer
-
Figure Market Size and Growth Rate of Pancreatic Cancer
-
Figure Market Size and Growth Rate of Others
-
Table USA T-Cell Immunotherapy Production by Regions
-
Table USA T-Cell Immunotherapy Production Share by Regions
-
Figure USA T-Cell Immunotherapy Production Share by Regions in 2016
-
Figure USA T-Cell Immunotherapy Production Share by Regions in 2021
-
Figure USA T-Cell Immunotherapy Production Share by Regions in 2027
-
Table USA T-Cell Immunotherapy Consumption by Regions
-
Table USA T-Cell Immunotherapy Consumption Share by Regions
-
Figure USA T-Cell Immunotherapy Consumption Share by Regions in 2016
-
Figure USA T-Cell Immunotherapy Consumption Share by Regions in 2021
-
Figure USA T-Cell Immunotherapy Consumption Share by Regions in 2027
-
Table West USA T-Cell Immunotherapy Consumption by Types from 2016 to 2027
-
Table West USA T-Cell Immunotherapy Consumption Share by Types from 2016 to 2027
-
Figure West USA T-Cell Immunotherapy Consumption Share by Types in 2016
-
Figure West USA T-Cell Immunotherapy Consumption Share by Types in 2021
-
Figure West USA T-Cell Immunotherapy Consumption Share by Types in 2027
-
Table West USA T-Cell Immunotherapy Consumption by End-Users from 2016 to 2027
-
Table West USA T-Cell Immunotherapy Consumption Share by End-Users from 2016 to 2027
-
Figure West USA T-Cell Immunotherapy Consumption Share by End-Users in 2016
-
Figure West USA T-Cell Immunotherapy Consumption Share by End-Users in 2021
-
Figure West USA T-Cell Immunotherapy Consumption Share by End-Users in 2027
-
Table South USA T-Cell Immunotherapy Consumption by Types from 2016 to 2027
-
Table South USA T-Cell Immunotherapy Consumption Share by Types from 2016 to 2027
-
Figure South USA T-Cell Immunotherapy Consumption Share by Types in 2016
-
Figure South USA T-Cell Immunotherapy Consumption Share by Types in 2021
-
Figure South USA T-Cell Immunotherapy Consumption Share by Types in 2027
-
Table South USA T-Cell Immunotherapy Consumption by End-Users from 2016 to 2027
-
Table South USA T-Cell Immunotherapy Consumption Share by End-Users from 2016 to 2027
-
Figure South USA T-Cell Immunotherapy Consumption Share by End-Users in 2016
-
Figure South USA T-Cell Immunotherapy Consumption Share by End-Users in 2021
-
Figure South USA T-Cell Immunotherapy Consumption Share by End-Users in 2027
-
Table Middle West USA T-Cell Immunotherapy Consumption by Types from 2016 to 2027
-
Table Middle West USA T-Cell Immunotherapy Consumption Share by Types from 2016 to 2027
-
Figure Middle West USA T-Cell Immunotherapy Consumption Share by Types in 2016
-
Figure Middle West USA T-Cell Immunotherapy Consumption Share by Types in 2021
-
Figure Middle West USA T-Cell Immunotherapy Consumption Share by Types in 2027
-
Table Middle West USA T-Cell Immunotherapy Consumption by End-Users from 2016 to 2027
-
Table Middle West USA T-Cell Immunotherapy Consumption Share by End-Users from 2016 to 2027
-
Figure Middle West USA T-Cell Immunotherapy Consumption Share by End-Users in 2016
-
Figure Middle West USA T-Cell Immunotherapy Consumption Share by End-Users in 2021
-
Figure Middle West USA T-Cell Immunotherapy Consumption Share by End-Users in 2027
-
Table Northeast USA T-Cell Immunotherapy Consumption by Types from 2016 to 2027
-
Table Northeast USA T-Cell Immunotherapy Consumption Share by Types from 2016 to 2027
-
Figure Northeast USA T-Cell Immunotherapy Consumption Share by Types in 2016
-
Figure Northeast USA T-Cell Immunotherapy Consumption Share by Types in 2021
-
Figure Northeast USA T-Cell Immunotherapy Consumption Share by Types in 2027
-
Table Northeast USA T-Cell Immunotherapy Consumption by End-Users from 2016 to 2027
-
Table Northeast USA T-Cell Immunotherapy Consumption Share by End-Users from 2016 to 2027
-
Figure Northeast USA T-Cell Immunotherapy Consumption Share by End-Users in 2016
-
Figure Northeast USA T-Cell Immunotherapy Consumption Share by End-Users in 2021
-
Figure Northeast USA T-Cell Immunotherapy Consumption Share by End-Users in 2027
-
Table Company Profile and Development Status of Kite Pharma
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Kite Pharma
-
Figure Sales and Growth Rate Analysis of Kite Pharma
-
Figure Revenue and Market Share Analysis of Kite Pharma
-
Table Product and Service Introduction of Kite Pharma
-
Table Company Profile and Development Status of Adaptimmune
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Adaptimmune
-
Figure Sales and Growth Rate Analysis of Adaptimmune
-
Figure Revenue and Market Share Analysis of Adaptimmune
-
Table Product and Service Introduction of Adaptimmune
-
Table Company Profile and Development Status of Juno Therapeutics
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Juno Therapeutics
-
Figure Sales and Growth Rate Analysis of Juno Therapeutics
-
Figure Revenue and Market Share Analysis of Juno Therapeutics
-
Table Product and Service Introduction of Juno Therapeutics
-
Table Company Profile and Development Status of Novartis
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Novartis
-
Figure Sales and Growth Rate Analysis of Novartis
-
Figure Revenue and Market Share Analysis of Novartis
-
Table Product and Service Introduction of Novartis
-
Table Company Profile and Development Status of Unum Therapeutics
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Unum Therapeutics
-
Figure Sales and Growth Rate Analysis of Unum Therapeutics
-
Figure Revenue and Market Share Analysis of Unum Therapeutics
-
Table Product and Service Introduction of Unum Therapeutics
-
Table Company Profile and Development Status of Altor Bioscience Corporation
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Altor Bioscience Corporation
-
Figure Sales and Growth Rate Analysis of Altor Bioscience Corporation
-
Figure Revenue and Market Share Analysis of Altor Bioscience Corporation
-
Table Product and Service Introduction of Altor Bioscience Corporation
-
Table Company Profile and Development Status of Takara Bio
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Takara Bio
-
Figure Sales and Growth Rate Analysis of Takara Bio
-
Figure Revenue and Market Share Analysis of Takara Bio
-
Table Product and Service Introduction of Takara Bio
-
Table Company Profile and Development Status of Cellectis
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Cellectis
-
Figure Sales and Growth Rate Analysis of Cellectis
-
Figure Revenue and Market Share Analysis of Cellectis
-
Table Product and Service Introduction of Cellectis
-
